(Q39202247)
Statements
Novel low molecular weight spirodiketopiperazine derivatives potently inhibit R5 HIV-1 infection through their antagonistic effects on CCR5 (English)
K Yoshimura
S Shibayama
H Habashita
H Tada
K Sagawa
T Miyakawa
M Aoki
D Fukushima